The study [35] hypothesizes that a higher Tcm/Teff ratio does not reflect the immune response against the tumor but rather the individual’s ability to mount this response, which can be potentiated by ICI, particularly anti-PD-1. This evidence concerns the gene PDCD1 and neoplasm.